BackNewAmsterdam Pharma Company NV - Warrants (15/11/2027) Overview
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) Return on Equity

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMSW) has a ROE of -41.1%, below the sector sector average of -5.71%.

Get informed when a big investor buys or sells

+ Follow

ROE

-41.10%

Return on Equity

-41.10%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMSW) FAQ

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMSW) currently reports a ROE of -41.1%. That is below the sector sector average of -5.71%. Use the charts on this page to explore NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s ROE history and peer comparisons.

NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s ROE of -41.1% is lower than the its sector sector average of -5.71%. That is roughly 619.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s current -41.1% should be judged against industry norms (sector average: -5.71%) and against NAMSW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -41.1%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.71%. From there, open related valuation or income-statement pages for NewAmsterdam Pharma Company NV - Warrants (15/11/2027), and consider following NAMSW for alerts when major investors trade the stock.